COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis

Abstract Background The SARS-CoV-2 pandemic was a challenge for health care systems worldwide. People with pre-existing chronic diseases have been identified as vulnerable patient groups. Furthermore, some of the drugs used for these chronic diseases such as antihypertensive drugs have been discusse...

Полное описание

Библиографические подробности

Главные авторы:	Roland Linder, Jonas Peltner, Anatoli Astvatsatourov, Willy Gomm, Britta Haenisch
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-02-01
Серии:	BMC Public Health
Предметы:	Case-control study COVID-19 Coronavirus SARS-CoV-2 Epidemiology Claims data
Online-ссылка:	https://doi.org/10.1186/s12889-024-21110-7
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!